Home » Stocks » AWH

Aspira Women's Health, Inc. (AWH)

Stock Price: $4.51 USD -0.09 (-1.96%)
Updated Aug 3, 2021 2:23 PM EDT - Market open
Market Cap 518.87M
Revenue (ttm) 4.93M
Net Income (ttm) -20.12M
Shares Out 108.66M
EPS (ttm) -0.20
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day August 3
Last Price $4.51
Previous Close $4.60
Change ($) -0.09
Change (%) -1.96%
Day's Open 4.60
Day's Range 4.40 - 4.65
Day's Volume 177,438
52-Week Range 2.47 - 10.54

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

AUSTIN, Texas, July 27, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that it will report financial results for the se...

6 days ago - GlobeNewsWire

Aspira Women's Health (AWH) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

2 weeks ago - Zacks Investment Research

AUSTIN, Texas, July 08, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) today announced its OVA1® risk assessment test for ovarian cancer in women with pelvic masses is considered medi...

3 weeks ago - GlobeNewsWire

AUSTIN, Texas, May 19, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that management will participate in and present a...

2 months ago - GlobeNewsWire

Aspira (AWH) delivered earnings and revenue surprises of 79.17% and 6.86%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Conference call scheduled for today, May13 at 4:30 p.m. ET Conference call scheduled for today, May13 at 4:30 p.m. ET

2 months ago - GlobeNewsWire

New Team Addition Is a Thought Leader in Reimbursement and Diagnostics New Team Addition Is a Thought Leader in Reimbursement and Diagnostics

2 months ago - GlobeNewsWire

Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Below is a repost of an article from Benzina.com, which features Schaeffer's V.P.

Other stocks mentioned: AA, SHAK, SONO, X
4 months ago - Schaeffers Research

Aspira (AWH) delivered earnings and revenue surprises of -1350.00% and 11.23%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Conference Call scheduled for today, March 25th at 4:30 p.m. ET Conference Call scheduled for today, March 25th at 4:30 p.m. ET

4 months ago - GlobeNewsWire

AUSTIN, Texas, March 25, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced it has entered into an agreement with Dana-Farb...

4 months ago - GlobeNewsWire

Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

AUSTIN, Texas, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced the appointment of Ms. Nicole Sandford to its Boa...

5 months ago - GlobeNewsWire

AUSTIN, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced management will participate and present in the 2...

5 months ago - GlobeNewsWire

Aspira will incorporate Management Recommendations from the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in the Aspira GenetiX report Aspira...

5 months ago - GlobeNewsWire

AUSTIN, Texas, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women's health company focused on gynecologic disease, today announced the pr...

5 months ago - GlobeNewsWire

AUSTIN, Texas, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women's health company focused on gynecologic disease, today announced it has...

5 months ago - GlobeNewsWire

These winners are positioned for gains even after COVID.

Other stocks mentioned: FLGT, GNMK, NTRA, CODX
6 months ago - The Motley Fool

Aspira to participate in the 10 th Annual LifeSci Advisors Corporate Access Event and  Biotech Showcase™ from January 6 – 15 th , 2021

6 months ago - GlobeNewsWire

AUSTIN, Texas, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced management will participate in the 2020 Canto...

Other stocks mentioned: VRML
10 months ago - GlobeNewsWire

Conference Call scheduled for today, August 13th at 4:30 p.m. ET Conference Call scheduled for today, August 13th at 4:30 p.m. ET

Other stocks mentioned: VRML
11 months ago - GlobeNewsWire

Conference Call scheduled for today, August 13th at 4:30 p.m. ET Conference Call scheduled for today, August 13th at 4:30 p.m. ET

Other stocks mentioned: VRML
11 months ago - GlobeNewsWire

AUSTIN, Texas, July 31, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it will report financial results for the secon...

Other stocks mentioned: VRML
1 year ago - GlobeNewsWire

AUSTIN, Texas, July 01, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) (“ASPIRA”), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that ...

Other stocks mentioned: VRML
1 year ago - GlobeNewsWire

Vermillion, Inc. (NASDAQ: VRML) shares were trading higher on Wednesday, after the company announced it completed validation of new pre-surgical test offerings with OVA1 plus, including coronavirus anti...

Other stocks mentioned: VRML
1 year ago - Benzinga

AUSTIN, Texas, June 10, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, is excited to announce that its wholly-ow...

Other stocks mentioned: VRML
1 year ago - GlobeNewsWire

AUSTIN, Texas, June 09, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it is set to join th...

Other stocks mentioned: VRML
1 year ago - GlobeNewsWire

Vermillion's (VRML) CEO Valerie Palmieri on Q1 2020 Results - Earnings Call Transcript

Other stocks mentioned: VRML
1 year ago - Seeking Alpha

Conference Call scheduled for today, May 14th at 4:30 p.m. ET Conference Call scheduled for today, May 14th at 4:30 p.m. ET

Other stocks mentioned: VRML
1 year ago - GlobeNewsWire

Vermillion, Inc. (VRML) CEO Valerie Palmieri on Q4 2019 Results - Earnings Call Transcript

Other stocks mentioned: VRML
1 year ago - Seeking Alpha

Vermillion, Inc. (VRML) CEO Valerie Palmieri on Q3 2019 Results - Earnings Call Transcript

Other stocks mentioned: VRML
1 year ago - Seeking Alpha

Vermillion's (VRML) CEO Valerie Palmieri on Q2 2019 Results - Earnings Call Transcript

Other stocks mentioned: VRML
1 year ago - Seeking Alpha

Vermillion's (VRML) CEO Valerie Palmieri on Q1 2019 Results - Earnings Call Transcript

Other stocks mentioned: VRML
2 years ago - Seeking Alpha

Vermillion, Inc. (VRML) CEO Valerie Palmieri on Q4 2018 Results - Earnings Call Transcript

Other stocks mentioned: VRML
2 years ago - Seeking Alpha

About AWH

Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. It provides OVA1, Overa, and Ova1PLUS to detect the risk of ovarian malignancy. The company also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, it owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address crit... [Read more...]

Industry
Diagnostics & Research
Founded
1993
CEO
Valerie Palmieri
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
AWH
Full Company Profile

Financial Performance

In 2020, AWH's revenue was $4.65 million, an increase of 2.49% compared to the previous year's $4.54 million. Losses were -$17.91 million, 17.5% more than in 2019.

Financial Statements